ERBB2 and gastric cancer: For those with recurrent or metastatic GC, the standard care includes chemotherapy alongside an immune checkpoint inhibitor for HER2-negative cases, trastuzumab for HER2-positive cases, and zolbetuximab for Claudin 18.2-positive cases [6] [7] [8].